Therabionic GmbH received U.S. FDA humanitarian device exemption (HDE) for its P1 device for at-home treatment of hepatocellular carcinoma, which accounts for 80% of all liver cancers, in patients who have failed first- and second-line therapies.
Radio-wave treatment shows some promise against liver cancer zmescience.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zmescience.com Daily Mail and Mail on Sunday newspapers.
Study shows safety and efficacy of radio-wave therapy for liver cancer patients
Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer. The therapy also showed a benefit in overall survival.
The study findings appear online in 4Open, a journal published by EDP Sciences.
HCC accounts for nearly 90% of all liver cancers, and current survival rates are between six and 20 months. Currently, there are limited treatment options for patients with this advanced liver cancer.
Boris Pasche, M.D., Ph.D., chair of cancer biology and director of Wake Forest Baptist s Comprehensive Cancer Center
Radio-wave therapy is safe for liver cancer patients sanantoniopost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sanantoniopost.com Daily Mail and Mail on Sunday newspapers.